NON-MUSCLE INVASIVE
Clinical trials for NON-MUSCLE INVASIVE explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Grown tumor organoids could guide bladder cancer treatment
Disease control OngoingThis trial tests whether lab-grown miniature tumors, called organoids, can help choose the best chemotherapy for people with intermediate-risk bladder cancer. Tumor samples are taken during surgery and grown in the lab. After testing several drugs on the organoids, the most effec…
Matched conditions: NON-MUSCLE INVASIVE
Phase: PHASE2 • Sponsor: Roland Seiler-Blarer • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New Virus-Based therapy targets bladder cancer after BCG fails
Disease control TerminatedThis study tested a treatment called CG0070, a virus designed to attack cancer cells, in people with high-grade non-muscle invasive bladder cancer. Participants had already tried standard therapy (BCG) without success and chose not to have their bladder removed. The goal was to s…
Matched conditions: NON-MUSCLE INVASIVE
Phase: PHASE2 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC